Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Market Vectors Biotech Etf (NY: BBH)
72.77 USD  -0.20 (-0.27%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News
Fund Overview
Market Vectors Biotech Etf
Sector
Exchange Traded NY
Net Assets 330.85M
Inception Date
Related Funds XDPOX DPO RET XMUJX
Quote
Price 72.77
Volume 67,108
Last Trade May 24, 6:40pm
Change (%)
-0.20 (-0.27%)
Prev. Close 72.97
YTD %
+36.02%
Dividend Yield 0.02%
Performance
YTD
+19.27 (36.02%)
1 Month
+1.39 (1.95%)
3 Month
+15.01 (25.99%)
6 Month
+18.85 (34.96%)
1 Year
+26.93 (58.75%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Bristol-Myers, Jazz Pharmaceuticals Lead Pharma Rally
May 22, 2013
Drugmakers of all stripes rocketed in early trade Wednesday, although many pared gains sharply before the end of the session. The Amex Pharmaceutical Index trimmed its initial 1.3% gain to less than... Read More
from Investor's Business Daily - Investing RSS
Biotech HOLDRs Trust Crosses Above its 10-day MA (BBH)
May 22, 2013
from Comtex SmarTrend® News Briefs
Top News
More News
Ex-Div Reminder for Amgen (AMGN)
May 10, 2013
On 5/14/13, Amgen Inc (AMGN) will trade ex-dividend, for its quarterly dividend of $0.47, payable on 6/7/13. As a percentage of AMGN's recent stock price of $104.54, this dividend works out to... Read More
from Dividend Channel
7 ETFs Up More Than 10% This Earnings Season
May 10, 2013
Wall Street is coming out of earnings season with more steam than before. Even though not all reports were positive, it seems that investors are unwilling to allow anything to slow down returns. With... Read More
from ETF Database
S&P Highlights Biotech ETFs
May 10, 2013
Bolstered by an accommodating Food & Drug Administration and promising recent clinical results for drugs aimed at treating conditions such as hepatitis C and multiple sclerosis, biotechnology stocks... Read More
from Latest Articles from Benzinga.com
Investors Clamor for Generic Drug ETF
May 06, 2013
Big pharma will soon lose patents on blockbuster drugs, boosting the market for cheap generic drug producers. Too bad there isn’t an exchange traded fund that tracks global generic drug makers. The... Read More
from ETF Trends
Uptrend Call Working As Biotech HOLDRs Trust Stock Rises 30.9% (BBH)
May 02, 2013
from Comtex SmarTrend® News Briefs
QGEN Makes Notable Cross Below Critical Moving Average
May 01, 2013
In trading on Wednesday, shares of Qiagen N. . Read More
from Market News Video
Biotech HOLDRs Trust Bullish Moving Average Crossover Alert (BBH)
April 25, 2013
from Comtex SmarTrend® News Briefs
Wednesday's ETF with Unusual Volume: BBH
April 24, 2013
The Biotech ETF (BBH) is seeing unusually high volume in afternoon trading Wednesday, with over 225,000 shares traded versus three month average volume of about 73,000. Shares of BBH were off about 3%... Read More
from ETF Channel
Wednesday's ETF Movers: GDX, BBH
April 24, 2013
In trading on Wednesday, the Gold Miners ETF (GDX) is outperforming other ETFs, up about 3.6% on the day. Components of that ETF showing particular strength include shares of Harmony Gold Mining (HMY),... Read More
from ETF Channel
Biotech Mutual Funds Show ETFs Are The Place to Be
April 22, 2013
In March, we compared a a popular energy sector ETF and a comparable mutual fund with the idea being to figure out when relevant factors are considered, which vehicle is best for investors. That... Read More
from Latest Articles from Benzinga.com
A Look Ahead: This Week's ETFs to Watch
April 21, 2013
Market participants cannot look back on the dour performance turned in by U.S. stocks last week. The one where the S&P 500 slumped 2.1 percent and turned not only its worst weekly performance of 2013,... Read More
from Latest Articles from Benzinga.com
Weekly ETF Leaders and Laggards: BBH, GLDX
April 19, 2013
The Biotech ETF (BBH) outperformed other ETFs this week, up about 2.3%. Components of that ETF showing particular strength this week include shares of Vertex Pharmaceuticals (VRTX), up about 50.6% and... Read More
from ETF Channel
Vertex News Lifts Biotech ETFs
April 19, 2013
Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ: VRTX ) are soaring by more than 55 percent early Friday and have touched a new all-time high after the company announced late Thursday that... Read More
from Latest Articles from Benzinga.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here